Version July 2025
| Screening visit | Referral pathway |
| No BCRL | |
| No symptoms or signs of BCRL | Continue propsective surveillance |
| Arm volume <10% RVC | |
| L-Dex <6.5 | |
| Subclinical BCRL | |
| Subjective symptoms of increased | High Risk (eg, ALND): referral and treatment with CLT Low Risk (eg, SLNB): ongoing prospective surveillance or referral to CLT for evaluation and treatment |
| Arm heaviness or volume | |
| BCRL | |
| Subjective symptoms | Referral to CLT for evaluation and treatment |
| Extremity edema on clinical examination | |
| Arm volume ≥10% RVC | |
| L-Dex >6.5 | |
